サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363097

乱用薬物検査サービスの市場規模、シェア、動向分析レポート：薬物タイプ別、地域別、セグメント予測、2023年～2030年

Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD ), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
乱用薬物検査サービスの市場規模、シェア、動向分析レポート：薬物タイプ別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月20日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乱用薬物検査サービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、乱用薬物検査サービスの世界市場規模は、2023年から2030年にかけてCAGR 3.91％で拡大し、2030年には85億4,000万米ドルに達する見込みです。

発達した検査施設網の存在と中毒の蔓延が市場成長の主な促進要因です。さらに、地域社会におけるさまざまな薬物使用の動向の増加や、違法薬物やアルコールの検出のための検査の重要性は、需要を促進すると予想されます。そのため、世界中で継続的に検査が提供されていることが成長を後押ししています。

さらに、精神疾患患者の増加や薬物の消費による入院が需要を押し上げています。例えば、2023年1月、SAMHSAによって、精神疾患と物質使用レベルの詳細を示す薬物使用と健康に関する全国調査結果（2021年）が発表されました。この調査では、12歳以上の人口の16.5％（4,630万人）が薬物使用障害を持っており、2,950万人がアルコール使用障害、2,400万人が薬物使用障害と分類されています。

加えて、人々の意識の高まり、若者や成人の中毒や違法薬物使用の治療に対するアンメットニーズは、乱用薬物検査サービス産業の需要を押し上げると予測されています。例えば、2020年8月、Averhealthはアリゾナ州のTreatment Assessment Screening Centerの薬物検査サービスの買収を発表しました。したがって、新興国における中毒の負担を最小限に抑えるためにプレイヤーの焦点を増加させることは、市場の収益を推進しています。この要因によって、企業は乱用ケースに対する革新的で効果的なサービスを開発するようになっています。

同様に、COVID-19の大流行も市場に適度な影響を与えています。パンデミックの間、若者や成人の間で大麻／マリファナやオピオイドへの中毒が増加したため、検出サービスに対する一定の需要が生じた。国連薬物犯罪事務所（UNODC）によると、2020年には世界で約2億7,500万人が薬物を使用し、2021年の世界薬物報告書によると、3,600万人以上が薬物使用障害に苦しんでいます。このような要因から、パンデミック後のサービスに対する要求が高まっています。

さらに、主要参入企業は、世界の足跡と製品ポートフォリオを拡大するために、とりわけ契約、M&A、パートナーシップ、発売などの戦略に取り組んでいます。例えば、2022年12月、Omega Laboratoriesはカナダで尿中乱用薬物検査サービスを開始しました。さらに2023年1月からは、分子検査を補完する尿検査を提供する予定です。毒物検査サービスの拡大は、カナダで利用可能な限られた選択肢に代わる選択肢を消費者に提供することになります。

乱用薬物検査サービス市場レポート・ハイライト

  • 大麻/マリファナ分野は2022年に市場で最大の収益シェアを占め、大麻/マリファナ中毒の蔓延、医療スクリーニング、雇用検査の需要により、予測期間中に最も速い成長率で成長すると予測されます。
  • 2022年の市場シェアは北米が最大。老舗の市場プレイヤーの存在、様々な中毒治療への需要、消費の拡大、若者の大麻/マリファナ中毒がこの地域の成長を牽引しています。
  • 乱用薬物検査サービスを展開する主要企業は、その存在感を維持するため、常に製品の発売と地理的拡大に注力しています。

目次

第1章 乱用薬物検査サービス市場：調査手法と範囲

第2章 乱用薬物検査サービス市場：エグゼクティブサマリー

  • 市場スナップショット
  • 薬剤タイプのスナップショット
  • 競合情勢のスナップショット

第3章 乱用薬物検査サービスの市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
  • 市場促進要因分析
    • 薬物乱用の蔓延とその治療への需要の高まり
    • 薬物乱用を監視する政府の取り組みの増加
    • アルコールと薬物の検査を義務付ける厳格な法律
  • 市場抑制要因分析
    • 一部の国では薬物検査はプライバシー権の侵害とみなされる
  • ポーターのファイブフォース分析
  • PESTLE分析

第4章 乱用薬物検査サービス市場：薬物タイプ別推定・動向分析

  • 乱用薬物検査サービス市場：薬物タイプの変動分析
  • アルコール
  • 大麻/マリファナ
  • コカイン
  • オピオイド
  • アンフェタミンとメタンフェタミン
  • LSD
  • その他

第5章 乱用薬物検査サービス市場：地域別ビジネス分析

  • 地域市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 新たなローンチ
    • パートナーシップ
    • 取得
    • コラボレーション
  • 主要企業の市場シェア分析、2022年
  • 企業ヒートマップ分析
  • 企業プロファイル
    • QUEST DIAGNOSTICS
    • ABBOTT
    • CLINICAL REFERENCE LABORATORY（CRL）, INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • CORDANT HEALTH SOLUTIONS
    • LEGACY MEDICAL SERVICES
    • DRUGSCAN
    • OMEGA LABORATORIES, INC.
    • PSYCHEMEDICS CORPORATION
    • MILLENNIUM HEALTH, LLC
    • MAYO CLINIC LABORATORIES
    • PRECISION DIAGNOSTICS
    • AMERICAN SUBSTANCE ABUSE PROFESSIONALS（ASAP）, INC.
    • UNITED STATES DRUG TESTING LABORATORIES（USDTL）, INC.
    • LGC GROUP
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Drug of Abuse Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 5 North America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 7 Canada Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 8 Europe Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 Europe Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 10 Germany Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 11 UK Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 12 France Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Spain Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 14 Italy Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Denmark Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 16 Norway Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 17 Sweden Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 20 Japan Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 21 China Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 22 India Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 23 Australia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 24 South Korea Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 25 Thailand Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Latin America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Latin America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 28 Brazil Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 29 Mexico Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 30 Argentina Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 33 Saudi Arabia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 34 South Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 35 UAE Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global drug of abuse testing services market - Key market driver analysis
  • Fig. 7 Global drug of abuse testing services market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global drug of abuse testing services market - Porter's analysis
  • Fig. 10 Global drug of abuse testing services market - PESTEL analysis
  • Fig. 11 Global drug of abuse testing services market drug type outlook key takeaways
  • Fig. 12 Global drug of abuse testing services market: Drug type movement analysis
  • Fig. 13 Alcohol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Cannabis/Marijuana market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Cocaine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Amphetamine & Methamphetamine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 LSD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 Global drug of abuse testing services market: Regional movement analysis
  • Fig. 22 North America drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 24 Canada drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 25 Europe drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 27 UK drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 28 France drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 29 Spain drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 30 Italy drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 31 Denmark drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 32 Norway drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 36 China drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 37 India drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 40 Thailand drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 44 Argentina drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 45 MEA drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 46 South Africa drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 47 Saudi Arabia drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 48 UAE drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 49 Kuwait drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 50 Strategy framework
目次
Product Code: GVR-2-68038-254-9

Drug Of Abuse Testing Services Market Growth & Trends:

The global drug of abuse testing services market size is expected to reach USD 8.54 billion by 2030, expanding at a CAGR of 3.91% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The presence of a developed laboratory network and the prevalence of addiction are key drivers for market growth. Furthermore, the increasing trend of different drug use in the community and the importance of testing for the detection of illicit drugs and alcohol is expected to drive the demand. Thereby, continued test offering across the globe has fueled the growth.

Additionally, rising psychiatric disorders patients and hospitalizations due to the consumption of the drugs have boosted the demand. For instance, January 2023, National Survey on Drug Use and Health Results Detailing Mental Illness & Substance Use Levels (2021) was announced by SAMHSA. The survey mentioned that 16.5% of the aged 12 or older population (or 46.3 million) people had a substance use disorder wherein 29.5 million people were classified to have alcohol use disorder & 24 million people had drug use disorder.

In addition, the growing awareness among the population and the unmet need for treatment of addiction and illicit medication use among youth and adults is projected to boost the demand for the drug of abuse testing services industry. For instance, in August 2020, Averhealth announced the acquisition of the drug testing services of the Treatment Assessment Screening Center in Arizona. Therefore, increasing the focus of players to minimize the burden of addiction in emerging countries propels the market revenue. This factor has led companies to develop innovative and effective services for abuse cases.

Likewise, the COVID-19 pandemic has moderately impacted the market. During the pandemic, a constant demand for detection services was attributable to the increased addiction to Cannabis/Marijuana and opioids among the youth and adult population. According to United Nations Office on Drugs and Crime (UNODC), in 2020, around 275 million people used drugs worldwide, while according to the 2021 World Drug Report, over 36 million population suffered from drug use disorders. This factor has led to rising requirements for services post-pandemic.

Furthermore, the key participants are engaged in strategies such as agreements, mergers & acquisitions, partnerships, and launches, among others, to expand their global footprints and product portfolio. For instance, in December 2022, Urine Drugs of Abuse testing services was launched by Omega Laboratories in Canada. Adding to that from January 2023, the laboratory will offer urine testing to complement its molecular testing. The expansion of toxicology services will offer consumers an alternative to limited options available in Canada.

Drug Of Abuse Testing Services Market Report Highlights:

  • Cannabis/Marijuana segment held the largest revenue share of the market in 2022 and is anticipated to grow at the fastest growth rate over the forecast period owing to the prevalence of cannabis/marijuana addiction, demand for medical screening, and employment testing drives the growth
  • North America held the largest share of the market in 2022. The presence of well-established market players, demand for various addiction treatments, growing consumption, and addiction to cannabis/marijuana among youth drive regional growth
  • Key players operating in the drug of abuse testing services constantly focus on product launches and geographical expansion to maintain their presence

Table of Contents

Chapter 1. Drug of Abuse Testing Services Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Drug Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Drug of Abuse Testing Services Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Drug Type Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Drug of Abuse Testing Services Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. High prevalence of substance abuse & growing demand for its treatment
    • 3.4.2. Increase in government initiatives to monitor substance abuse
    • 3.4.3. Stringent law mandating alcohol and drug testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. Drug testing is considered a violation of privacy rights in some countries
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. Drug of Abuse Testing Services Market: Drug Type Estimates & Trend Analysis

  • 4.1. Drug of Abuse Testing Services Market: Drug Type Movement Analysis
  • 4.2. Alcohol
    • 4.2.1. Alcohol Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Cannabis/Marijuana
    • 4.3.1. Cannabis/Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cocaine
    • 4.4.1. Cocaine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Opioids
    • 4.5.1. Opioids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Amphetamine & Methamphetamine
    • 4.6.1. Amphetamine & Methamphetamine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. LSD
    • 4.7.1. LSD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug of Abuse Testing Services Market: Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Drug of Abuse Testing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Reimbursement Scenario
      • 5.2.2.5. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Reimbursement Scenario
      • 5.2.3.5. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Reimbursement Scenario
      • 5.3.2.5. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Reimbursement Scenario
      • 5.3.3.5. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Reimbursement Scenario
      • 5.3.4.5. Competitive Scenario
    • 5.3.5. Spain
      • 5.3.5.1. Spain Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Reimbursement Scenario
      • 5.3.5.5. Competitive Scenario
    • 5.3.6. Italy
      • 5.3.6.1. Italy Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Reimbursement Scenario
      • 5.3.6.5. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Reimbursement Scenario
      • 5.3.7.5. Competitive Scenario
    • 5.3.8. Norway
      • 5.3.8.1. Norway Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Reimbursement Scenario
      • 5.3.8.5. Competitive Scenario
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Reimbursement Scenario
      • 5.3.9.5. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia-Pacific Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Reimbursement Scenario
      • 5.4.2.5. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Reimbursement Scenario
      • 5.4.3.5. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Reimbursement Scenario
      • 5.4.4.5. Competitive Scenario
    • 5.4.5. Australia
      • 5.4.5.1. Australia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Reimbursement Scenario
      • 5.4.5.5. Competitive Scenario
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Reimbursement Scenario
      • 5.4.6.5. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Reimbursement Scenario
      • 5.4.7.5. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.2.2. Key Country Dynamics
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement Scenario
      • 5.5.2.5. Competitive Scenario
    • 5.5.3. Mexico
      • 5.5.3.1. Mexico Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.3.2. Key Country Dynamics
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement Scenario
      • 5.5.3.5. Competitive Scenario
    • 5.5.4. Argentina
      • 5.5.4.1. Argentina Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.4.2. Key Country Dynamics
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. Reimbursement Scenario
      • 5.5.4.5. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement Scenario
      • 5.6.2.5. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement Scenario
      • 5.6.3.5. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement Scenario
      • 5.6.4.5. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement Scenario
      • 5.6.5.5. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. New Launch
    • 6.2.2. Partnerships
    • 6.2.3. Acquisition
    • 6.2.4. Collaboration
  • 6.3. Key Company Market Share Analysis, 2022
  • 6.4. Company Heat Map Analysis
  • 6.5. Company Profiles
    • 6.5.1. QUEST DIAGNOSTICS
      • 6.5.1.1. Company Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. ABBOTT
      • 6.5.2.1. Company Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. CLINICAL REFERENCE LABORATORY (CRL), INC.
      • 6.5.3.1. Company Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
      • 6.5.4.1. Company Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. CORDANT HEALTH SOLUTIONS
      • 6.5.5.1. Company Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. LEGACY MEDICAL SERVICES
      • 6.5.6.1. Company Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. DRUGSCAN
      • 6.5.7.1. Company Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. OMEGA LABORATORIES, INC.
      • 6.5.8.1. Company Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. PSYCHEMEDICS CORPORATION
      • 6.5.9.1. Company Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. MILLENNIUM HEALTH, LLC
      • 6.5.10.1. Company Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Strategic Initiatives
    • 6.5.11. MAYO CLINIC LABORATORIES
      • 6.5.11.1. Company Overview
      • 6.5.11.2. Financial Performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Strategic Initiatives
    • 6.5.12. PRECISION DIAGNOSTICS
      • 6.5.12.1. Company Overview
      • 6.5.12.2. Financial Performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Strategic Initiatives
    • 6.5.13. AMERICAN SUBSTANCE ABUSE PROFESSIONALS (ASAP), INC.
      • 6.5.13.1. Company Overview
      • 6.5.13.2. Financial Performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Strategic Initiatives
    • 6.5.14. UNITED STATES DRUG TESTING LABORATORIES (USDTL), INC.
      • 6.5.14.1. Company Overview
      • 6.5.14.2. Financial Performance
      • 6.5.14.3. Product Benchmarking
      • 6.5.14.4. Strategic Initiatives
    • 6.5.15. LGC GROUP
      • 6.5.15.1. Company Overview
      • 6.5.15.2. Financial Performance
      • 6.5.15.3. Product Benchmarking
      • 6.5.15.4. Strategic Initiatives